Role for α1,2-fucosyltransferase and histo-blood group antigen H type 2 in resistance of rat colon carcinoma cells to 5-fluorouracil

International Journal of Cancer

Volumn 85, Issue 1, 2000, Pages 142-148

  Cordel, Sandrine ^a   Goupille, Caroline ^a   Hallouin, Florence ^a   Meflah, Khaled ^a   Le Pendu, Jacques ^a  

^a INSTITUT DE BIOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIGEN; FLUOROURACIL; FUCOSYLTRANSFERASE; H2 ANTIGEN; ANTINEOPLASTIC ANTIMETABOLITE; GALACTOSIDE 2 ALPHA L FUCOSYLTRANSFERASE; GALACTOSIDE 2-ALPHA-L-FUCOSYLTRANSFERASE; TUMOR ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CELL SURFACE; COLON CARCINOMA; DRUG EFFICACY; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; ADENOCARCINOMA; ANIMAL; CANCER TRANSPLANTATION; CELL CULTURE; COLON TUMOR; DRUG RESISTANCE; DRUG SCREENING; ENZYMOLOGY; EXPERIMENTAL NEOPLASM; FEMALE; FLOW CYTOMETRY; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; RAT; RAT STRAIN;

ADENOCARCINOMA; ANIMALS; ANTIGENS, NEOPLASM; ANTIMETABOLITES, ANTINEOPLASTIC; COLONIC NEOPLASMS; DRUG RESISTANCE, NEOPLASM; FEMALE; FLOW CYTOMETRY; FLUOROURACIL; FUCOSYLTRANSFERASES; H-2 ANTIGENS; IMMUNOHISTOCHEMISTRY; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; RATS; RATS, INBRED STRAINS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0033622328     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000101)85:1<142::AID-IJC24>3.0.CO;2-K     Document Type: Article

References (31)

1. AYROLDI, E., CANNARILE, L., MIGLIORATI, G., BARTOLI, A., NICOLETTI, I. and RICCARDI, C., CD44 (Pgp-1) inhibits CD3 and dexamethasone-induced apoptosis. Blood, 86, 2672-2678 (1995).
2. BECK, A., ETIENNE, M.C., CHERADAME, S., FISCHEL, J.L., FORMENTO, P., RENÉE, N. and MILANO, G.A., Role of dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil. Europ. J. Cancer, 30A, 1517-1522 (1994).
3. BLOTTIÈRE, H.M., BURG, C., ZENNADI, R., PERRIN, P., BLANCHARDIE, P., BARA, J., MEFLAH, K. and LE PENDU, J., Involvement of histo-blood-group antigens in the susceptibility of colon carcinoma cells to natural killer-mediated cytotoxicity. Int. J. Cancer, 52, 609-618 (1992).
4. BLOTTIÈRE, H.M., MÉNORET, A., GRÉGOIRE, M., DOUILLARD, J.Y., MEFLAH, K. and LE PENDU, J., Analysis of the state of differentiation of two rat colon carcinoma clones with distinct tumorigenic properties. Biol. Cell, 72, 239-247 (1991).
5. CHAUFFERT, B., DIMANCHE-BOITREL, M.T., GENNE, P., PETIT, J.M., ONIER, N. and JEANNIN, J.F., Chimiothérapie expérimentale d'une carcinomatose péritonéale d'origine colique chez le rat. Gastroenterol. Clin. Biol., 16, 215-219 (1992).
6. CORDEL, S., HEYMANN, M.F., BOISTEAU, O., OLIVER, L., LE PENDU, J., GRÉGOIRE, M. and MEFLAH, K., 5-Fluorouracil-resistant colonic tumors are highly responsive to sodium butyrate/interleukin-2 bitherapy in rats. Int. J. Cancer, 73, 924-928 (1997).
7. DE GRAFF, T.W., SLOT, S.S., PETERS, G.J. and VAN DIJK, W., Changes in glycosylation of L1210 cells after exposure to various antimetabolites. Europ. J. Cancer, 29A, 1760-1765 (1993).
8. DICKSTEIN, B., WOSIKOWSKI, K. and BATES, S.E., Resistance to cytotoxic agents in ZR75B human breast cancer cells transfected with epidermal growth factor receptor. Mol. cell. Endocrinol., 110, 205-211 (1995).
9. FISHER, T.C., MILNER, A.E., GREGORY, C.D., JACKMAN, A.L., WYNNE AHERNE, G., HARTLEY, J.H., DIVE, C. and HICKMAN, J.A., bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways. Cancer Res., 53, 3321-3326 (1993).
10. GOUPILLE, C., HALLOUIN, F., MEFLAH, K. and LE PENDU, J., Increase of rat colon carcinoma cells tumorigenicity by α(1-2)fucosyltransferase gene transfection. Glycobiology, 7, 221-229 (1997).
11. GÜNTHERT, A.R., STRÄTER, J., VON REYHER, U., HENNE, C., JOOS, S., KORETZ, K., MOLDENHAUER, G., KRAMMER, P.H. and MÖLLER, P., Early detachment of colon carcinoma cells during CD95 (APO-1/Fas)-mediated apoptosis. I. De-adhesion from hyaluronate by shedding of CD44. J. Cell Biol., 134, 1089-1096 (1996).
12. HALLOUIN, F., GOUPILLE, C., BUREAU, V., MEFLAH, K. and LE PENDU, J., Increased tumorigenicity of rat colon carcinoma cells after α 1,2-fucosyltransferase FTA antisense cDNA transfection. Int. J. Cancer, 80, 606-611 (1999).
13. ITZKOWITZ, S., Carbohydrates changes in colon carcinoma. Acta pathol. microbiol. immunol. Scand., 100 (Suppl. 27), 173-180 (1992).
14. KINSELLA, A.R., SMITH, D. and PICKARD, M., Resistance to chemotherapeutic antimetabolites: a function of salvage pathway involvement and cellular response to DNA damage. Brit. J. Cancer, 75, 935-945 (1997).
15. LABARRIÈRE, N., PIAU, J.P., OTRY, C., DENIS, M., LUSTENBERGER, P., MEFLAH, K. and LE PENDU, J., H blood group antigen carried by CD44v6 modulates tumorigenicity of rat colon carcinoma cells. Cancer Res., 54, 6275-6281 (1994).
16. LESUFFLEUR, T., KORNOWSKI, A., AUGERON, C., DUSSAULX, E., BARBAT, A., LABOISSE, C. and ZWEIBAUM, A., Increased growth adaptability to 5-fluorouracil and methotrexate of HT-29 sub-populations selected for their commitment to differentiation. Int. J. Cancer, 49, 731-737 (1991a).
17. LESUFFLEUR, T., KORNOWSKI, A., LUCCIONI, C., MULERIS, M., BARBAT, A., BEAUMATIN, J., DUSSAULX, E., DUTRILLAUX, B. and ZWEIBAUM, A., Adaptation to 5-fluorouracil of the heterogenous human colon tumor cell line HT-29 results in the selection of cells committed to differentiation. Int. J. Cancer, 49, 721-730 (1991b).
18. LOWE, S.W., RULEY, H.E., JACKS, T. and HOUSMAN, D.E., p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74, 957-967 (1993).
19. MARTIN, F., CAIGNARD, A., JEANNIN, J.F., LECLERC, A. and MARTIN, M., Selection by trypsin of two sublines of rat colon cancer cells forming progressive or regressive tumors. Int. J. Cancer, 32, 623-627 (1983).
20. MÉNORET, A., OTRY, C., LABARRIÈRE, N., BREIMER, M.E., PILLER, F., MEFLAH, K. and LE PENDU, J., The expression of carbohydrate blood group antigens correlates with heat resistance. J. Cell Sci., 108, 1691-1701 (1995).
21. NAITOH, H., NAKAJIMA, T., NAGAMACHI, Y. and YAZAWA, S.A., Clinicopathological evaluation of anti-fucosylated antigens antibody (YB-2) in colorectal carcinoma. Glycosylation Dis., 1, 31-36 (1994).
22. ORIOL, R., MOLLICONE, R., COULLIN, P., DALIX, A.M. and CANDELIER, J.J., Genetic regulation of the expression of ABH and Lewis antigens in tissues. Acta pathol. microbiol. immunol. Scand., 100 (Suppl. 27), 173-180 (1992).
23. PETERS, G.J., VAN DER WILT, C.L., VAN TRIEST, B., CODACCI-PISANELLI, G., JOHNSTON, P.G., VAN GROENINOEN, C.J. and PINEDO, H.M., Thymidylate synthase and drug resistance. Europ. J. Cancer, 31A, 1299-1305 (1995).
24. PIAU, J.P., LABÅRRIÈRE, N., DABOUIS, G. and DENIS, M.G., Evidence for two distinct α(1-2)fucosyltransferases differentially expressed throughout the rat colon. Biochem. J., 300, 623-626 (1994).
25. PRITCHARD, D.M., WATSON, A.J., POTTEN, C.S., JACKMAN, A.L. and HICKMAN, J.A., Inhibition by uridine but not thymidine of p53-dependent intestinal apoptosis initiated by 5-fluorouracil: evidence for the involvement of RNA perturbation. Proc. nat. Acad. Sci. (Wash.), 94, 1795-1799 (1997).
26. RAJAN, V.P., LARSEN, R.D., AJMERA, S., ERNST, L.K. and LOWE, J.B., A cloned human DNA restriction fragment determines expression of a GDP-1-fucose: β-D-galactoside 2-α-L-fucosyltransferase in transfected cells. J. biol. Chem., 264, 11158-11167 (1989).
27. SINGH, G., DORWARD, A., MOOREHEAD, R. and SWEET, S., Novel mechanisms of resistance to cancer chemotherapy. Cancer J., 8, 304-307 (1995).
28. SOMMERS, C.L., HECKFORD, S.E., SKERKER, J.M., WORLAND, P., TORRI, J.A., THOMPSON, E.W., BYERS, S.W. and GELMANN, E.P., Loss of epithelial markers and acquisition of vimentin expression in adriamycin- and vinblastin-resistant human breast cancer cell lines. Cancer Res., 52, 5190-5197 (1992).
29. SUN, J., THURIN, J., COOPER, H.S., WANG, P., MACKIEWICZ, M., STEPLEWSKI, Z. and BLASZCZYK-THURIN, M., Elevated expression of H type GDP fucose: β-D-galactoside 2-α-L-fucosyltransferase is associated with human colon adenocarcinoma progression. Proc. nat. Acad. Sci. (Wash.), 92, 5724-5728 (1995).
30. WANG, F.S., ASCHELE, C., SOBRERO, A., CHANG, Y.M. and BERTINO, J.R., Decreased folylpolyglutamate synthetase expression: a novel mechanism of fluorouracil resistance. Cancer Res., 53, 3677-3680 (1993).
31. ZENNADI, R., GARRIGUE, L., RINGEARD, S., MÉNORET, A., BLANCHARDIE, P. and LE PENDU, J., Analysis of factors associated with the tumorigenic potential of 12 tumor clones derived from a single rat colon adenocarcinoma. Int. J. Cancer, 52, 934-940 (1992).